{
    "title": "FDA neurosciences chief Billy Dunn to leave immediately, analysts raise concern",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11804179/FDA-neurosciences-chief-Billy-Dunn-leave-immediately-analysts-raise-concern.html",
    "date": "2023-02-28",
    "keywords": [
        "drug",
        "tuesday",
        "departure",
        "reata",
        "decision",
        "role",
        "monday",
        "exit",
        "dunn",
        "biogen",
        "year",
        "food",
        "administration",
        "health",
        "regulator",
        "wall",
        "street",
        "stance",
        "term",
        "disorder",
        "message",
        "agencys",
        "deputy",
        "director",
        "teresa",
        "buracchio",
        "basis",
        "office",
        "neuroscience",
        "agency",
        "analyst",
        "maury",
        "raycroft",
        "research",
        "note",
        "suspicion",
        "fda",
        "speculation",
        "session",
        "inc",
        "eisai",
        "cos",
        "aduhelm",
        "lack",
        "evidence",
        "disease",
        "approval",
        "relyvrio",
        "panel",
        "sclerosis",
        "market",
        "trial",
        "reporting",
        "roy",
        "bengaluru",
        "editing",
        "humer",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}